《2019年富士膠片綜合報告 - 富士膠片(82頁英文版).pdf》由會員分享,可在線閱讀,更多相關《2019年富士膠片綜合報告 - 富士膠片(82頁英文版).pdf(82頁珍藏版)》請在三個皮匠報告上搜索。
1、FUJIFILM Holdings Corporation INTEGRATED REPORT 2019 IMPROVING THE FUTURE CORPORATE SLOGAN At Fujifi lm, we are continuously innovating creating new technologies, products and services that inspire and excite people everywhere. Our goal is to empower the potential and expand the horizons of tomorrow
2、s businesses and lifestyles. The Unchanging Values of the Fujifi lm Group We will use leading-edge, proprietary technologies to provide top-quality products and services that contribute to the advancement of culture, science, technology and industry, as well as improved health and environmental prot
3、ection in society. Our overarching aim is to help enhance the quality of life of people worldwide. Corporate PhilosophyVision What the Fujifi lm Group Will Strive to Achieve Anchored by an open, fair and clear corporate culture and with leading-edge, proprietary technologies, Fujifilm is determined
4、to remain a leading company by boldly taking up the challenge of developing new products and creating new value. 1INTEGRATED REPORT 2019 General Disclaimer The information contained in this integrated report concerning business performance and results forecasts, excluding statements of objective fac
5、t, are based on managements views that have been made in accordance with information available at the time of issue. These forward-looking statements involve risks and uncertainties. Actual results may materially differ from those discussed in the forward-looking statements due to a variety of facto
6、rs, including trends in economic conditions and markets in which the Company operates as well as fluctuations in foreign currency exchange rates. The contents of amendments to earnings releases for prior fiscal years, which were announced in 2017, have reflected on the numerical data for FY2011/3 to
7、 FY2016/3. Unless otherwise specified in this integrated report, the information herein is as of March 31, 2019. Integrated Report (Editorial Policy) This report mainly contains financial and non-financial information regarding the Fujifilm Groups corporate activities that is believed to be highly i
8、mportant for shareholders/investors as well as growth strategies and other relevant matters. We also disclose the Fujifilm Groups business and diverse CSR activities to a wide spectrum of stakeholders, including local communities and society, custom- ers, investors, business partners and employees,
9、through FUJIFILM Holdings corporate site, including this Integrated Report and our Sustainability Report. Please visit our site for more information. FUJIFILM Holdings Corporation Corporate Site FUJIFILM Holdings Corporation Sustainability Report About the cover page “NEVER STOP” is the key message
10、of our global branding campaign launched in countries all over the world, aiming to accurately communicate the Fujifi lm Groups ambition to expand into a broad array of businesses and em- brace challenges in new areas. Since our founding, we have continued to not only grow as a company, but also sol
11、ve various social issues while drawing on our cutting-edge proprietary technology to spark innovation and providing new value. Our key message represents the Fujifi lm Groups commitment to constantly moving forward. About the Fujifilm Group 2 4 5 6 8 10 12 14 16 Management Message 18 20 The Fujifilm
12、 Groups Value Creation 24 28 28 32 34 38 40 40 44 46 50 50 54 60 Financial Information/Non-Financial Information 62 64 67 68 75 Corporate Information 77 79 CONTENTS Value Creation History Sources of Corporate Value Technological Capabilities Proprietary technologies underpinning growth and expansion
13、 into various fi elds Towards being a corporation that instigates changes Value Creation Process Business Portfolio Financial Highlights Non-Financial Highlights Message from the CEO Interview with the COO Strategies for Value Creation Economic Value Feature 1 A Future Enabled by Next Generation AI
14、Technology Imaging Solutions Healthcare for example, in addition to hitherto typical activities like assisting the creation of inventions, submitting patent applications, and acquiring right, we conduct strategic analyses of competitors and ad- dress industry standards for the purpose of achieving b
15、usi- ness superiority. By collaborating with business departments and R (2) further accelerating growth; and (3) investing for the future. Document Solutions JPY 1,005.6 billion 41% Imaging Solutions JPY 386.9 billion 16% Healthcare namely, X-ray diagnostic imaging, medical IT, endoscopes, ultra-sou
16、nd, and in-vitro diagnostics (IVD). In particular, our picture archiving com- munication systema platform for managing and storing image data taken with various medical diagnostic imaging equipmenthas maintained the top global share*1 since FY2018/3 and we continue to propose medical IT-focused comp
17、rehensive solutions to our customers. Up ahead, by combining our image processing and image analysis tech- nologies that we have honed over many years, we hope to further develop AI-driven technology to provide diagnostic support to physicians and generate further growth by pro- viding products and
18、services that improve workfl ow. The bio CDMO business is expanding at a healthy clip having benefi tted mainly from the expansion of production capacity we have carried out since FY2018/3. By har- nessing the engineering technology we have accumulated in the research, development, and production of
19、 photo- graphic film, along with the biotechnology know-how of our Group companies, we are constantly expanding pro- duction capacity and pushing ahead with the development of technologies for further enhancing productivity. Some examples include Apollo X, which employs next-genera- tion high-produc
20、tivity technology to achieve industry-lead- ing antibody production, as well as fully integrated con- tinuous production systems from culturing to purifi cation. In August 2019 we turned the manufacturing subsidiary of US-based biopharmaceutical giant Biogen into a con- solidated subsidiary. This ac
21、quisition provided us with the facilities to carry out mass production and means we can meet broad-ranging contract needs for either small or large volumes. Moreover, we aim to further accelerate the pace of business growth by drawing on the strengths in the area of process development and manufactu
22、ring of various types of biopharmaceuticals, including antibodies and gene therapy drugs. Meanwhile, we think investments for generating future growth are needed in the pharmaceuticals and regener- ative medicine businesses. Not only are we engaging in more effi cient development and working to redu
23、ce SG FUJIFILM Cellular Dynamics, a leading company in the development and production of iPS cells; FUJIFILM Wako Pure Chem- ical Corporation and FUJIFILM Irvine Scientific, both ex- perts in the fi eld of culture media. In aiming to further improve profi tability in FY2020/3, the final year of VISI
24、ON2019, we intend to expand our exist- ing businesses and keep on accelerating research and development. Sales of culture media needed for cell culture remain brisk and in anticipation of greater demand going forward, we made the decision in July 2019 to begin construction of a culture media product
25、ion plant in Europe. As a leading company, we intend to expand our busi- ness operations and contribute to the industrialization of regenerative medicine by fully maximizing synergies mainly between the following Group companies: Japan Tissue Engineering, the fi rst company in Japan to develop and p
26、rotection by providing top-quality products and services and help further enhance the quality of life of people world- wide as well as to do business openly, fairly, and clearly. In 2017, the Group formulated and fully committed itself to putting into action two plans: the Sustainable Value A Since
27、its foundation, the Fujifi lm Group has continued to place CSR at the very core of business management to fi nd solutions to social issues through its business activities. The essence of our corporate philosophy and vision is to contribute to the advancement of society and environmental Q Please tel
28、l us about your ESG initiatives. and consolidate the strategic partnerships we have with other fi rms that possess highly competitive cloud services. We hope to make our customers operations more effi- cient and contribute to work-style reforms by providing a wide array of solutions and services for
29、 different sectors, including manufacturing, finance, healthcare, logistics, public services, and education, as well as for different types of operations, such as information security or doc- ument management. Secondly, in the production services fi eld, we will make every effort to expand sales by
30、rolling out products and services that meet customer needs, but also deliver more services that aim to support overall print- ing workfl ow. We are looking to achieve business growth by strengthening collaboration between Fujifi lms Graphic Systems Business Division and Inkjet Business Division and
31、maximizing Group synergies. Based on the measures outlined above, we aim to achieve the FY2021/3 operating profit margin target of 10% in the document business one year ahead of schedule. The cash we steadily generate will be invest- ed back into the aforementioned growth fields with the goal of dri
32、ving up sales and establishing a business platform capable of delivering sustained growth. A With the aim of building a robust platform for the document business so that it can withstand tough business conditions, instead of simply establishing a structure that calls for efficiency or reducing headc
33、ount, we are implementing company-wide operational reforms and striving to improve profitability. More specifically, we are undertaking various on-site initiatives such as reducing CoGS by speeding up development, streamlining opera- tions with the use of RPA and so on. As a result, the benefits of
34、our initiatives in monetary terms in FY2019/3 came to JPY 31 billion, JPY 4 bil- lion more than our forecast. Also, after partially revis- ing our schedule, we have pushed back the expected completion of structural reforms from FY2020/3 to FY2021/3 but we still expect to curtail overall costs by JPY
35、 2.9 billion and realize benefits of JPY 55 billion (vs. FY2017/3) in line with our initial forecast. Going forward, based on a resilient earnings structure established as a result of our operational reforms, we will endeavor to boost sales in the growth fi elds of solutions and CDP, which helps com
36、panies disclose and manage information on their environmental impacts. The companies that join the RE100 are committed to achieving 100% renewable electricity used in their business activities. *4 Return on equity *5 Return on invested capital *6 Cash conversion cycle incorporate ESG perspectives in
37、to management and busi- ness strategies. Discussions are currently in progress ahead of the for- mulation of our next medium-term management plan, but at the same time, we will take steps to also review the SVP2030 in response to changes in society and our busi- ness environment. Based on these plan
38、s, while we recognize that social is- sues could pose longer-term risks for the Company as we aim to realize a sustainable society, we also think that the solving of societys challenges presents an opportunity to create new businesses. For this reason, we will continue to put in place a strong syste
39、m through which we can take the initiative to develop new technologies and prod- ucts and to propose solutions. The Fujifi lm Group aims to achieve sustained growth by continuing to meet the expectations and earn the trust of shareholders and all other stakeholders. Plan 2030 (SVP2030), a CSR plan t
40、argeted at helping to achieve the SDGs and other goals related to issues faced by society; and the medium-term management plan, VI- SION2019, which runs through FY2020/3, as a concrete action plan for realizing this ambition. In September 2019, we have adopted “ Fujifi lm Group Em- ployee Wellness D
41、eclaration,” which stipulates our intention to actively maintain and enhance the wellness of our employ- ees given their role in supporting these business activities. We also actively take part in global initiatives for the pur- pose of accelerating measures intended to resolve climate change-relate
42、d issues; for example, we have endorsed the TCFD*2 and joined the RE100*3. We are committed to ensur- ing that Fujifi lm Group initiatives contribute to society and will vigorously promote these activities on a Group-wide basis. In June 2019, we exhaustively reorganized our CSR Group to establish a
43、new ESG Division. This division now reports directly to the president and will work harder to We intend to steadily achieve the targets we set out in VI- SION2019, which comes to an end this fi scal year. And in order to generate sustained growth and enhance corporate value up ahead, we will make a
44、point of engaging in dialogue with shareholders and stepping up efforts to continuously To our shareholders create products and services of value to meet the expecta- tions of society and earn its trust. We hope to meet your expectations for future growth of the Fujifi lm Group and I look forward to
45、 your continued support for many more years to come. be assigned a ROIC target to enhance capital efficiency according to its stage of growth (improving profitability; accelerating growth; or investing for the future) and man- aged so that we can achieve our overall ROE target. At the same time as p
46、ursuing cost reductions in each busi- ness, we will actively engage in M it uses AI to enable the design of new com- pounds that could not have been imag- ined before. Hibimikke This social infrastructure diag- nostic imaging service greatly improves the efficiency of crack inspection for bridges, t
47、unnels, and other infrastructure. This service uses the cloud to automatically synthesize images from multiple photographs of bridg- es, for example, that have been uploaded to a server and applies AI-based image analysis to detect cracks. Further, it creates a com- prehensive dataset concerning the
48、 de- tected cracks. Research and Development Framework for Next Generation AI In 2016, Fujifi lm established the Informatics Research Laboratory, which conducts research and development for the purpose of reinforcing and expanding application of information infrastructure technologies that address I
49、oT, AI, and other increasingly sophisticated forms of ICT. That same year we established the ICT Strategy Management Offi ce, which promotes the company-wide shift to ICT. Moreover, in 2018 we opened Brain(s) as an AI technology development base. In addition to enhancing cooperation towards AI use within the Group, we are building a re- search and development framework that advances joint research with academia and collaboration with other com- panies as a means of supporting the development of next generation AI. AI Pharma- ceutica